Sep 05 2023 42 mins 7
KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Patrick Malone and Mack Healy discuss the biopharma software juggernaut, Schrödinger. We dive into:
- Schrödinger's biophysics-based drug discovery platform, and the distinction from machine learning approaches
- A dissection of Schrödinger's software business, as well as co-development partnerships and internal therapeutic programs
- The story of Schrödinger collaboration with Nimbus on a TYK2 program, resulting in a $4B+ acquisition by Takeda
- and more
For updates from KdT, please subscribe to our Substack.
Show Notes:
